Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Athena 2 Trial
NCT07248228Phase 2Recruiting
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Jul 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Phase 2, randomised trial in brain metastases (2 arms), sponsored by Case Comprehensive Cancer Center. Primary endpoints: Time to neurocognitive failure at 12 months, Hopkins Verbal Learning Test-Revised at 12 months and 3 more. Started Jul 2026; status: recruiting.
02
Conditions
brain metastases
Beyond the preview
Go deeper on NCT07248228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07248228.